Sorin's Mitroflow valve comes of age – trial
This article was originally published in Clinica
Cardiovascular giant Sorin has posted data showing its Mitroflow aortic pericardial heart valve still works 21 years after implantation. The information, which appears in the September issue of the Journal of Thoracic and Cardiovascular Surgery, is "the longest patient follow-up ever published in the history of pericardial valves", according to the Milan, Italy-based firm. It shows the biological valve, launched in Europe in 1982, to have "excellent durability" in addition to the "superior haemodynamic performance" Sorin already claims for the device.